Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.43 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €68.66 | €100.00 | 45.645% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.51 | €9.21 | 1723.168% |
| Rhythm Pharmaceuticals | 15 | 0 | 3 | 0 | €35.60 | €45.98 | 29.157% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.61 | €3.70 | 130.100% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €121.00 | €124.93 | 3.247% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.05 | €24.13 | 60.353% |
| Drägerwerk AG & Co. KGaA ST | 2 | 0 | 0 | 0 | €44.30 | - | - |
| Medtronic plc | 9 | 1 | 0 | 0 | €76.45 | €93.46 | 22.244% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €205.90 | €204.50 | -0.680% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €40.27 | €48.50 | 20.437% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| Bastide Le Confort | 1 | 0 | 1 | 0 | €19.46 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.78 | €4.00 | 43.885% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.69 | €4.16 | 146.371% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.14 | €116.81 | 20.247% |
| UCB S.A. | 2 | 0 | 0 | 0 | €122.75 | - | - |
| Cigna Corp. | 17 | 0 | 3 | 0 | €325.65 | €342.35 | 5.129% |
| Vertex Pharmaceuticals Inc. | 44 | 2 | 8 | 0 | €390.60 | €404.41 | 3.534% |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.78 | €35.99 | 25.036% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €22.00 | €24.18 | 9.913% |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €96.00 | €109.94 | 14.525% |